Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKinsey
Harvard Business School
Medtronic
Mallinckrodt

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021228


Email this page to a colleague

« Back to Dashboard

NDA 021228 describes DETROL LA, which is a drug marketed by Upjohn and is included in one NDA. It is available from three suppliers. Additional details are available on the DETROL LA profile page.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 021228
Tradename:DETROL LA
Applicant:Upjohn
Ingredient:tolterodine tartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021228
Medical Subject Heading (MeSH) Categories for 021228
Suppliers and Packaging for NDA: 021228
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-01 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01)
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-02 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-02)
Paragraph IV (Patent) Challenges for 021228
Tradename Dosage Ingredient NDA Submissiondate
DETROL LA CAPSULE, EXTENDED RELEASE;ORAL tolterodine tartrate 021228 2007-07-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength2MG
Approval Date:Dec 22, 2000TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength4MG
Approval Date:Dec 22, 2000TE:ABRLD:Yes

Expired US Patents for NDA 021228

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.